bosulif

Generic: bosutinib

Labeler: pfizer laboratories div pfizer inc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name bosulif
Generic Name bosutinib
Labeler pfizer laboratories div pfizer inc
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

bosutinib monohydrate 100 mg/1

Manufacturer
Pfizer Laboratories Div Pfizer Inc

Identifiers & Regulatory

Product NDC 0069-1014
Product ID 0069-1014_ca8600d9-46e6-402d-89f9-bc6a156bf751
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA217729
Listing Expiration 2027-12-31
Marketing Start 2024-01-02

Pharmacologic Class

Classes
bcr-abl tyrosine kinase inhibitors [moa] kinase inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00691014
Hyphenated Format 0069-1014

Supplemental Identifiers

UPC
0300691014158 0300690504308 0300690193014 0300690136011 0300690135014
UNII
844ZJE6I55

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bosulif (source: ndc)
Generic Name bosutinib (source: ndc)
Application Number NDA217729 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 150 CAPSULE in 1 BOTTLE (0069-1014-15)
source: ndc

Packages (1)

0069-1014-15 150 CAPSULE in 1 BOTTLE (0069-1014-15)

Ingredients (1)

bosutinib monohydrate (100 mg/1)

Linked Drug Pages (1)

BOSULIF ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "ca8600d9-46e6-402d-89f9-bc6a156bf751", "openfda": {"upc": ["0300691014158", "0300690504308", "0300690193014", "0300690136011", "0300690135014"], "unii": ["844ZJE6I55"], "spl_set_id": ["adc84ad5-a04d-4fee-9ba8-91f7abd928e3"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 CAPSULE in 1 BOTTLE (0069-1014-15)", "package_ndc": "0069-1014-15", "marketing_start_date": "20240102"}], "brand_name": "BOSULIF", "product_id": "0069-1014_ca8600d9-46e6-402d-89f9-bc6a156bf751", "dosage_form": "CAPSULE", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Kinase Inhibitor [EPC]"], "product_ndc": "0069-1014", "generic_name": "Bosutinib", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BOSULIF", "active_ingredients": [{"name": "BOSUTINIB MONOHYDRATE", "strength": "100 mg/1"}], "application_number": "NDA217729", "marketing_category": "NDA", "marketing_start_date": "20240102", "listing_expiration_date": "20271231"}